Abstract
BackgroundAbatacept, a soluble, fully human fusion protein which selectively inhibits T-cell activation via competitive binding to CD80/CD86, decreases serum levels of cytokines and inflammatory proteins implicated in the pathogenesis of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have